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Several arenaviruses cause hemorrhagic fever disease in humans and pose a signiﬁcant public health concern in their endemic
regions. On the other hand, the prototypic arenavirus LCMV is a superb workhorse for the investigation of virus-host interactions
and associated disease. The arenavirus small RING ﬁnger protein called Z has been shown to be the main driving force of virus
budding. The budding activity of Z is mediated by late (L) domain motifs, PT/SAP, and PPXY, located at the C-terminus of Z.
This paper will present the current knowledge on arenavirus budding including the diversity of L domain motifs used by diﬀerent
arenaviruses.Wewillalsodiscusshowimprovedknowledgeofarenavirusbuddingmayfacilitatethedevelopmentofnovelantiviral
strategies to combat human pathogenic arenaviruses.
1.Introduction
A r e n a v i r u s e sa r ee n v e l o p e dv i r u s e sw i t hab i s e g m e n t e dn e g -
ative strand (NS) RNA genome with coding capability
for four known genes: nucleoprotein (NP), surface gly-
coprotein precursor (GPC), polymerase (L), and matrix-
like (Z) proteins. Despite their limited genome and pro-
teomic complexity, arenaviruses are able to exhibit very
diﬀerent phenotypic infection outcomes ranging from long-
term subclinical chronic infections on their natural rodent
hosts [1] to hemorrhagic fever (HF) disease in humans,
infected through mucosal exposure to aerosols or by direct
contact of abrade skin with infectious material. Thus, Lassa
virus (LASV), the causative agent of Lassa fever (LF) is
estimated to infect several hundred thousand individuals
yearly in its endemic regions of West Africa, resulting in
a high number of LF cases associated with high morbidity
and signiﬁcant mortality. Likewise, Junin virus (JUNV)
causes Argentine HF, a severe illness with hemorrhagic and
neurological manifestations and a case fatality of 15–30%,
whereas the Machupo (MACV) and Guanarito (GTOV)
arenavirusesemergedascausativeagentsofHFinBoliviaand
Venezuela, respectively. On the other hand, the prototypic
arenavirus, lymphocytic choriomeningitis virus (LCMV),
is a superb workhorse for the investigation of virus-host
interactions including mechanisms of virus control and
clearance by the host immune defenses, as well as viral
counteracting measures leading to chronic infection and
associated disease [2, 3]. Moreover, evidence indicates that
the globally distributed prototypic arenavirus LCMV is a
neglected human pathogen of clinical signiﬁcance, especially
in cases of congenital infection. In addition, LCMV poses
a special threat to immunocompromised individuals, as
illustrated by cases of transplant-associated infections by
LCMV with a fatal outcome in the USA and Australia. Public
health concerns about arenavirus infections are aggravated
by the lack of licensed vaccines and current therapy being
limited to the use of the nucleoside analog ribavirin, which
is only partially eﬀective, requires early and intravenous
administration for optimal activity, and can cause signiﬁcant
side eﬀects. Therefore, it is important to develop novel
and eﬀective antiarenaviral strategies, a task that should
be facilitated by a better understanding of the arenavirus
molecular and cell biology.2 Advances in Virology
Arenavirus
NP
NP
Z
GPC
GPC
Virion structure
Ribosome
Ribosome
5
5
3
3
Z
L
L
Genome organization
IGR
IGR
Figure 1: Arenavirus virion structure and genome organization.
Arenaviruses are enveloped viruses with a bisegmented negative
strand RNA genome. Each genome segment uses an ambisense-
codingstrategytodirectthesynthesisoftwoviralpolypeptides.The
S (ca 3.5kb) segment encodes for the viral nucleoprotein (NP) and
glycoprotein precursor (GPC). GPC is posttranslational processed
by the cellular protease S1P into the mature virion surface GP1
and GP2. The L (ca 7.3kb) segment encodes for the virus RNA-
dependent RNA polymerase (L) and a small RING ﬁnger protein
(Z)thatisfunctionallythearenaviruscounterpartofthematrix(M)
proteinfoundinmanyenvelopednegativestrandRNAviruses.IGR,
noncoding intergenic region.
T h ea r e n a v i r u ss m a l lR I N Gﬁ n g e rZp r o t e i nh a sb e e n
shown to be the main driving force of budding. This paper
will examine our current understanding of arenavirus bud-
ding and discuss potential implications for the development
of novel targeting strategies to combat human pathogenic
arenaviruses.
2. ArenavirusGenomeOrganizationand
Life Cycle
Arenavirusesareenvelopedviruseswithabisegmentednega-
tivestrand(NS)RNAgenomeandalifecyclerestrictedtothe
cell cytoplasm. Virions are pleomorphic but often spherical
and covered with surface glycoprotein spikes. Both the large,
L (ca 7.3kb) and small, S (ca 3.5kb) genome RNA species
use an ambisense-coding strategy to direct the synthesis of
two polypeptides in opposite orientation, separated by a
noncoding intergenic region (IGR) with a predicted folding
of a stable hairpin structure [1]( Figure 1). The S RNA
encodes the viral glycoprotein precursor, GPC, (ca 75kDa)
and the nucleoprotein, NP, (ca 63kDa), whereas the L RNA
encodes the viral RNA-dependent RNA polymerase (RdRp,
or L polymerase) (ca 200kDa) and a small (ca 11kDa)
RING ﬁnger protein Z that is functionally the counterpart
of the matrix (M) protein found in many enveloped NS RNA
viruses.
Consistentwithabroadhostrangeandcell-typetropism,
a highly conserved and widely expressed cell surface protein
α-Dystroglycan (α-DG) has been identiﬁed as a main recep-
tor for LCMV, LASV, and several other arenaviruses [4,
5], whereas the human transferrin receptor (TfR) was
identiﬁed as the primary receptor used by several New World
(NW) arenavirus [6]. Upon receptor binding, virions are
internalized using an endocytotic pathway that is either
clathrin-independent or clathrin-dependent for Old World
(OW) and NW arenavirus, respectively [5]. Interestingly,
cell entry of OW LCMV and LASV are independent of
caveolin, dynamin, actin, or small GTPases Rab5 and Rab7
but cholesterol-dependent [7–9].Following the releaseof the
viral ribonucleoprotein into the cytoplasm of the infected
cells, the associated polymerase directs the biosynthetic pro-
cesses involved in RNA replication and gene transcription.
Assembly and cell release of infectious progeny involve the
association of the viral ribonucleoprotein core with the
surface GP complex, a process that is required for the
production of infectious virions, which bud from the plasma
membrane (PM).
3. ArenavirusZ StructureandFunction
Results derived from minigenome- (MG-) based assays
identiﬁed NP and L as the minimal viral transacting factors
required for eﬃcient RNA synthesis mediated by the virus
polymerase [10–12]. Z was not required for RNA replication
or transcription, but rather Z has been shown to exhibit
a dose-dependent inhibitory eﬀect on both transcription
and replication of LCMV, Tacaribe virus (TACV), and LASV
MGs [10, 12–14]. The inhibitory activity of Z on RNA
synthesis by the LCMV polymerase did not require the N-
terminus or C-terminus of Z, whereas the RING domain
was strictly required but not suﬃcient [13, 14]. RING
domains are known to mediate protein-protein interactions,
and Z protein has been documented to interact with a
variety of host cellular proteins including PML [15, 16]
and translation initiation factor eIF4E [15–18]. The Z-
PML interaction was reported to result in disruption of
PML nuclear bodies and redistribution of PML to the
cytoplasm, but the biological implications of this remain to
be determined. On the other hand the Z-eIF4E interaction
was found to impair eIF4E-dependent translation through
its RING domain [16]. Interestingly, expression of Interferon
regulatory factor 7 (IRF7), a key factor in the regulation
of type I interferon (IFN) production by pDCs, is highly
dependent on 4E [19]. Therefore, it is plausible that Z might
mediate inhibition of IRF7 expression in arenavirus-infected
pDCs and, thus, contributing to the mechanisms by which
arenaviruses overcome the innate immune response by the
host.
The possible contribution of RING-mediated Z-host cel-
lular protein interactions to arenavirus budding is currently
unknown. Notably, arenavirus Z proteins have a strictly
conserved W residue in proximity to the second conserved
C residue within the RING, a feature characteristic of
RING proteins with E3 ligase activity involved in ubiquitin-
dependent protein degradation. However, preliminary evi-
dence indicated that LASV Z protein lacked ubiquitin-
ligating activity in the presence of a variety of E2 enzymes
including Ubc4 and Cdc34/Ubc3 [16]. Whether arenavirus
Z proteins may exhibit E3 ligase activity in the presence of
other E2 ubiquitin-conjugating enzymes and their biological
implications remain to be determined. Z has also been
implicatedinantagonizingthehostinnateimmuneresponse.Advances in Virology 3
Table 1: Summary of diﬀerent matrix (M) protein L domain motifs and cellular-interacting partners. Characterized viral M proteins,
accessory proteins, and their L domains are shown. ∗1: Alix/AIP1 has been shown to connect Z and NP [45, 46]. ∗2: there is a discrepancy
between the groups for Alix/AIP1 and Vps4 necessity for the budding [34, 35, 47].
Virus M protein Accessary protein L domain Nedd4-like Ubiquitin ligase Tsg101 Alix/AIP1 Vps4
HIV-1 Gag PTAP
 
 
 
YPXnL  
RSV Gag PPPY
  
YPXnL
VSV M PTAP x x
PPPY  
Ebola virus VP40 PTAP  
 
PPPY  
Marburg virus VP40 PPPY   
 
NP PSAP  
Lassa virus Z PTAP  
 
PPPY
LCMV Z PPPY   
Tacaribe virus Z ASAP x  
Mopeia virus
Z PTAP
 ∗1 PPPY
NP
Sendai virus M YLDL  ∗2
 ∗2
C  ∗2
Inﬂuenza virus x
NW, but not OW, arenavirus Z was shown to bind RIG-I and
inhibits IFN-β activation [20]. The recently reported NMR
structure of LASV Z [17] should facilitate future structure-
function studies aimed at the elucidation of the likely several
roles played by Z in the arenavirus life cycle.
4. The Z Protein Is the Driving Force of
ArenavirusBudding
The arenavirus Z protein has been shown to have bona ﬁde
budding activity [21–23]. Many enveloped viruses possess
a matrix (M) protein that is often the main driving force
of viral budding. Accordingly, the sole expression of this M
protein can produce virus-like particles (VLPs). Frequently
M proteins contain short amino acid motifs, called L (late)
domains that play a critical role in virus budding. To date,
the sequences PT/SAP, PPXY, and YPXnL (YPXL) have been
well established as L domain motifs [24–26]. In addition to
these L domains, the FPDL motif and several other short
amino acid motifs have also been reported to function as
L domains [24–26]. These L domain motifs exert their
activity in virus budding by mediating the interaction with
speciﬁc host cellular factors. Thus, the PT/SAP motif binds
to Tsg101, a component of ESCRT-I (endosomal sorting
complex required for transport-I) and initiates the budding
process [27, 28]. Vps4A/B is AAA-type ATPases involved in
catalyzing the disassembly and recycling of the membrane-
bound ESCRT complexes [29–31]. Evidence indicates that
the M protein of many, but not all, enveloped viruses have
the ability to recruit ESCRT complex to their budding sites
[24–26]. In addition to M, several other viral proteins,
including Sendai virus (SeV) C protein and Marburg virus
(MARV) NP, have been found to bind directly to ESCRT
proteins, Alix/AIP1, or both and contribute to the budding
process [24, 32–35]. Interestingly, some enveloped viruses,
including inﬂuenza, are able to execute very eﬃciently the
budding process without the ESCRT machinery [24, 36]. It is
worth noting that although the M protein of VSV contains
both PTAP and PPPY L domain motifs that interact with
Tsg101 and Nedd4; respectively, Tsg101 and Vps4A were not
required for eﬃcient budding of VSV [37]. Rous sarcoma
virus (RSV) Gag has a PPPY motif whose activity has been
shown to be regulated by late-domain-interacting protein
(LDI-1, Nedd4 chicken homolog) [38, 39]. Recently LYPSL
motif in RSV Gag was shown to serve as a second L domain
motif [40]. Table 1 summaries the variety of interactions
observed between L domains present in M proteins of
envelopedvirusesandtheirhostcellularinteractingpartners.
The family Arenaviridae currently includes 23 antigeni-
cally related viruses classiﬁed into two groups: OW and
NW. This classiﬁcation was originally established based on
serological cross-reactivity but is well supported by recent
sequence-based phylogenetic studies. OW arenaviruses con-
stitute a single lineage, while NW arenaviruses segregate into
clades A, B, and C. Recently, Lujo (LUJV) and Merino Walk
(MWAV)viruseswereidentiﬁedasnewlyidentiﬁedmembers
of the OW group [41, 42]. Interestingly, among diﬀerent
arenaviruses, there are signiﬁcant diﬀerences in the type of4 Advances in Virology
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Figure 2: Organization of arenavirus Z protein. All arenavirus Z proteins have G at position 2 (G2). Within the centrally located RING
domain, all known arenavirus Z proteins possess an YxxL (or YxxL-like) motif. At their C-terminus, arenavirus Z proteins have diﬀerent
types of L domains. Lassa virus (LASV), lymphocytic choriomeningitis virus (LCMV), Mopeia virus (MOPV), Merino Walk virus (MWAV),
Lujovirus(LUJV),Pichindevirus(PICV),Juninvirus(JUNV),Machupovirus(MACV),Sabiavirus(SABV),Tacaribevirus(TACV),Latino
virus (LATV), Whitewater Arroyo virus (WWAV).
L domain motifs present within their Z proteins (Figure 2).
LCMV Z contains a canonical PPPY L domain and the
PT/SAP-like domain STAP, whereas the Z of LASV and
Mopeia virus (MOPV) which as LCMV are also members
of the OW arenavirus group, contain, however, both PTAP
and PPPY canonical L domains, but the Z of the also OW
memberLujoviruscontainsonlythePTAPLdomain.Onthe
other hand, the Z of many of the NW arenaviruses including
JUNV, MACV, GATV, and Sabia (SABV) viruses contain the
PT/SAPLdomain.InadditionZproteinsofPichinde(PICV)
and Whitewater Arroyo- (WWAV) viruses contain PTAP
and APPY- (PPPY-like-) overlapping L domains, similar to
those of Ebola virus (EBOV) VP40 L domain (PTAPPEY).
Some arenavirus Z proteins do not contain canonical L
domains but rather closely related motifs as in the case of
the NW TACV and OW MWAV whose Z proteins contain
ASAPandPTCP,respectively,L-likedomains.Inaddition,all
known arenavirus Z proteins contain an YxxL motif within
the RING domain, but at least for TACV Z protein, it did
not inﬂuence the Z budding activity [43, 44]( Figure 2).Advances in Virology 5
The relative contribution of the diﬀerent types of L domains
to Z-mediated budding appears to be inﬂuenced by diﬀerent
factors including the virus species. Thus, for LASV the PPPY
Ldomainappearstohaveastrongercontributiontobudding
than the PTAP motif [22, 23]. PPPY motif seems to have
critical function compared to PTAP motif. In the case of
TACV, the L-like domain ASAP was found to lack budding
activity, and TACV Z-mediated budding was also Tsg101-
independent but Vps4A/B-dependent [43, 44].
In addition to the critical role played by the L domain
motifs in Z-mediated budding, glycine at position two
(G2) was strictly required for Z-mediated budding. G2 is
conserved among all known arenavirus Z proteins (Figure 2)
and is required for Z myristoylation and its subsequent
targeting of membranes [43, 48, 49]. Accordingly, mutation
G2A abrogated Z-mediated budding. Consistent with these
ﬁndings, treatment with 2-OHM (DL-2-hydroxymyristic
acid), an inhibitor of protein myristoylation, caused a
dramatic reduction on Z-mediated budding and production
of infectious virus progeny [43, 48].
5.Novel StrategiestoIdentify Cellular
Factors Contributingto Z-Mediated
Budding andSmall Molecule Inhibitorsof
Z-MediatedBudding
As with many other bona ﬁde viral budding proteins,
Z-mediated budding requires its interaction with speciﬁc
cellular factors within the endosomal/multivesicular body
pathway as we discuss below. The identiﬁcation and char-
acterization of LASV-Z-host protein interactions involved in
virus budding may uncover novel anti-arenavirus targets,
and facilitate the development of screening strategies to
identify drugs capable of disrupting viral budding and
thereby preventing virus propagation. The ability of Z to
direct self-budding in the absence of other viral proteins
should facilitate the development of assays amenable to
both genetics and chemical High Throughput Screening
(HTS) to identify host cellular proteins required for Z-
mediatedbudding,aswellassmallmoleculeinhibitorsofthis
process. To this end, the emergence of RNA interference as a
pathway that allows the modulation of gene expression has
enabled functional genetic screens in mammalian cell types.
Likewise, combinatorial chemical libraries have emerged as
a leading source of compounds for biological screens, and;
therefore, it should be feasible to identify small molecule
inhibitors of Z-mediated budding by screening chemical
libraries using appropriately designed cell-based assays of
Z-mediated budding. In this regard, recent ﬁndings have
shown that the fusion of the smaller (185 amino acids)
luciferase from Gaussia princeps (GLuc) to Z resulted in a
chimeric protein (Z-GLuc) that retain wild-type Z budding
activitythatcouldbemonitoredbydirectmeasuringofGLuc
activity in tissue culture supernatant of Z-GLuc transfected
cells. Initial studies have shown that this Z-GLuc-based
budding assay consistently exhibits high signal-to-noise ratio
(S/N) values (average 10-fold) [50], suggesting that it should
be amenable for the development of both genetic and
chemical HTS to identify host cellular genes contributing
to Z-mediated budding and small molecule inhibitors of Z-
mediated budding, respectively.
6. Contribution of the ESCRT Machinery to
ArenavirusBudding
The ESCRT machinery was originally identiﬁed as the Class
E subset of vacuolar protein sorting (VPS) genes required for
the correct sorting of soluble hydrolases from the yeast Golgi
to the vacuole [51–53]. The essential VPS-mediated sorting
step occurs during MVB (multi vesicular body) formation,
when ubiquitinated proteins and lipids present on the
limiting endosomal membrane are recognized and sorted
into endosomal membrane microdomains, which ultimately
invaginate and form vesicles that bud into the lumen to
create the MVB [54–56]. Vesicles of the MVB subsequently
fuse with lysosome, thereby exposing the internal vesicles
to the degrading lipases and proteases in this organelle.
ESCRT pathway is also involved in the membrane abscission
event at the conclusion of cell division [57, 58]. ESCRT-I
contains Tsg101, Vps37, Vps23, and Mvb12A/B and hasbeen
shown to be recruited from the cytoplasm to the surface of
maturing endosomes [29, 54–56, 59, 60]. Components of
ESCRT-I, especially Tsg101, recognize ubiquitinated protein
cargos and interact with ESCRT-II that participates in
protein sorting and vesicle formation. It should be noted
that Alix/AIP1 was found to bridge ESCRT-I and ESCRT-
III using a diﬀerent way to that used by ESCRT-II [61,
62]. ESCRT-III components also recruit another class E
proteins, Vps4A/B, which are AAA-type ATPases involved in
catalyzing the disassembly and recycling of the membrane-
bound ESCRT complexes [29–31]. Notably, the abscission
event during cellular cytokinesis, a process topologically
similar to endosomal vesicle formation, utilizes the same
ESCRT machinery [29, 58, 63].
Myristoylation of Z facilitates its attachment to the PM
where Z is likely recognized by Tsg101 through the PT/SAP
Ld o m a i nm o t i fp r e s e n ti nZ( Figure 3). However, there
is not direct biochemical evidence that Z binds to Tsg101
directly. Nevertheless, depletion of Tsg101 by siRNA resulted
in decreased levels of both LASV and LCMV Z-mediated
budding [21, 23]. Intriguingly, when the ASAP motif present
on TACV-Z protein was mutated to AAAA, VLP production
levels were not aﬀected, suggesting in contrast to LCMV
and LASV that TACV Z-mediated budding does not utilize
Tsg101 [43, 44]. However, results of siRNA-mediated deple-
tion and the use of dominant negative mutants indicated
that Vps4A/B was necessary for both LASV and TACV Z-
mediated budding activity [21, 43]. These results would
suggest that the last step within the ESCRT pathway is
necessary for both LASV and TACV Z-mediated budding.
ThebuddingactivityofsomeMproteinshasbeenshown
to be increased by the contribution of other viral proteins
as illustrated in the case of the nucleoprotein (NP) and
glycoprotein (GP) of the EBOV and MARV viruses [64, 65].
However, studies on LCMV and LASV Z-mediated budding
failed to uncover a contribution to budding by other viral6 Advances in Virology
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Figure 3: Model of arenavirus budding. Myristoylation of Z at G2
facilitates its interaction with the plasma membrane (PM), where Z
likely forms higher-order complexes. L domains located within the
C-terminus of Z facilitate its interactions with host cellular factors
to allow Z to utilize the ESCRT machinery of the cell for cell egress
(budding). SSP, stable signal peptide.
protein. In contrast, TACV NP was shown to enhance Z-
mediated VLP production [44].
Nevertheless, recently published work has shown that
Mopeia virus (MOPV) NP incorporation into VLP is
mediated by AIP1/Alix via interaction with the YLCL motif
present on Z [45, 46].
7. Tetherin/BST-2/CD317 as an Antagonist of
ArenavirusBudding
Tetherin was identiﬁed as an IFN-inducible antiviral cellular
factor that tether HIV virions at the PM [66, 67]. Subse-
quently studies have extended these ﬁndings to other viruses
[68]. As with other host innate immune defense factors,
several viruses have evolved mechanisms to counteract
tetherin-mediated antiviral activity [69]. Tetherin has been
shown to inhibit LASV Z-mediated budding [70]. Accord-
ingly, 293T cells constitutively expressing tetherin resulted
in decreased production levels of LASV and MACV virion
particle production, whereas siRNA-mediated knockdown
of endogenous tetherin in HeLa cells resulted in increased
production levels of LASV and MACV virion particle
production. These results would suggest that LASV does not
possess any tetherin-antagonizing function as described for
other viral proteins including HIV-1 Vpu, EBOV GP, and
KSHV K5 [66, 71–73].
Anissuethatremainstobeinvestigatedrelatestothecon-
tribution of tetherin to host protection and viral pathogene-
sis. An attractive hypothesis, but still without experimental
support, would be that tetherin could do to some degree
slow the process of virus propagation in vivo and thereby
facilitating both the action of the host innate immune
defense mechanisms and antigen presentation leading to
am o r er o b u s th o s ta d a p t i v ei m m u n er e s p o n s et h a tc o u l d
control and eliminate the virus.
8. Perspectiveson Arenavirus
Z-MediatedBudding
Current evidence indicates that many enveloped viruses
use the ESCRT machinery to exit from the cell. In the
case of arenavirus budding, Z-Tsg101 interaction appears
to facilitate access of Z to the ESCRT machinery. Despite
signiﬁcant recent progress in deﬁning the basic aspects of
arenavirus budding, there are still a large number of issues
that have not been investigated including: (1) Identiﬁcation
and functional characterization of host cellular factors that
interact with the PPXY L domain motif present in LASV,
LCMV, and some other arenavirus Z to facilitate virus bud-
ding. PPXY L domain motifs present in EBOV and MARV
VP40 have shown to mediate interaction with Nedd4.1 [74–
76]. Likewise, for several retroviruses, the interaction of Gag
PPXY L domains with ubiquitin ligases has been shown to
contribute to the regulation of viral budding [24, 25, 38,
39]. How ubiquitin ligases may regulate budding remains
unknown, but recent published data have shown arrestin-
related proteins to connect ubiquitin ligases and the ESCRT
machinery [77]. It is important to know whether speciﬁc
ubiquitin ligase may regulate Z-mediated budding, and if
so, what are the mechanism underlying this regulation. (2)
Ubiquitin or ubiquitin-like molecules (UBLs) have been
shown to modify the properties and budding activity of
HIV-1 Gag and EBOV VP40 proteins [78]. It is currently
unknown whether these protein modiﬁers may also have
a role in the regulation of arenavirus budding. (3) The
mechanisms by which arenavirus RNP interacts with Z and
GP to form budding mature infectious progeny are largely
unknown. (4) Whether the species-speciﬁc and type of cell
inﬂuence arenavirus budding and the biological implications
regarding the outcome of infection are issues that have not
been investigated.
Detailed understanding of the virus-host cell protein
interactions that direct arenavirus budding may uncover
novel targets for the development of antiviral drugs to
combat human pathogenic arenaviruses.
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